1. Home
  2. MASS vs BNR Comparison

MASS vs BNR Comparison

Compare MASS & BNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 908 Devices Inc.

MASS

908 Devices Inc.

HOLD

Current Price

$5.46

Market Cap

190.0M

Sector

Health Care

ML Signal

HOLD

Logo Burning Rock Biotech Limited

BNR

Burning Rock Biotech Limited

HOLD

Current Price

$22.80

Market Cap

216.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MASS
BNR
Founded
2012
2014
Country
United States
China
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
190.0M
216.9M
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
MASS
BNR
Price
$5.46
$22.80
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$9.00
N/A
AVG Volume (30 Days)
550.7K
54.2K
Earning Date
11-10-2025
11-20-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$65,045,000.00
$75,749,382.00
Revenue This Year
N/A
$136.32
Revenue Next Year
$19.55
N/A
P/E Ratio
N/A
N/A
Revenue Growth
36.21
5.56
52 Week Low
$1.92
$2.18
52 Week High
$9.34
$24.92

Technical Indicators

Market Signals
Indicator
MASS
BNR
Relative Strength Index (RSI) 42.80 58.13
Support Level $5.03 $19.10
Resistance Level $5.49 $24.92
Average True Range (ATR) 0.30 2.36
MACD 0.03 -0.02
Stochastic Oscillator 40.85 67.01

Price Performance

Historical Comparison
MASS
BNR

About MASS 908 Devices Inc.

908 Devices Inc manufactures medical devices. It has developed a suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the critical problems in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company geographically derives maximum revenue from United States, and also has its presence in Europe, Middle East and Africa, Americas and Other and Asia Pacific.

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.

Share on Social Networks: